Although a complete understanding of factors defining low SMD remains elusive, emerging evidence has linked it to insulin resistance and abnormal insulin signalling, including the activation of leptin‐IGF‐1 signalling that is also reported to cause CDK4/6i resistance preclinically [13, 30].S3 These factors contribute to increased systemic inflammation and oxidative stress. The gene discussed is LEP; the disease is Insulin resistance.